置管还是不置管？在一家三级转诊医院使用无管顺行输尿管支架置入系统。
To tube or not to tube? Utilising a tubeless antegrade ureteric stenting system in a tertiary referral hospital.
作者信息
Looney Aisling T, Daly Padraig J A, Cullen Ivor M, MacMahon Peter, Kelly Ian M G
机构信息
Department of Urology, Department of Surgery, University Hospital Waterford, Ardkeen, Waterford, Ireland.
Department of Radiology, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland.
出版信息
Ir J Med Sci. 2019 Feb;188(1):283-288. doi: 10.1007/s11845-018-1826-x. Epub 2018 Apr 26.
INTRODUCTION
To assess the benefits and complications of developing a practice of single-stage primary ureteral stenting in a university hospital.
METHODS
A practice change developed from the traditional practice of multi-stage stenting to single-episode stent placement. To evaluate this change of practice, we retrospectively analysed data of 70 patients who underwent primary tubeless antegrade ureteric stenting and compared this group to the previous 54 patients who had a covering nephrostomy.
RESULTS
There was an overall success rate of 91.3% (85/93 stents having had tubeless antegrade stenting). There were no major and 33 minor complications. The comparative group of 54 patients whose stents had a covering nephrostomy had a median length of stay of 13.2 days compared to 7.4 days for the tubeless group.
CONCLUSION
Single-stage primary ureteric stenting is a safe practice to employ and has universal benefits for both the patient and the health service.
引言
评估在大学医院开展单阶段原发性输尿管支架置入术的益处和并发症。
方法
实践从传统的多阶段支架置入术转变为单次支架置入。为评估这种实践变化，我们回顾性分析了70例行原发性无管顺行输尿管支架置入术患者的数据，并将该组与之前54例行覆盖性肾造瘘术的患者进行比较。
结果
总体成功率为91.3%（93个支架中有85个成功进行了无管顺行支架置入）。无重大并发症，有33例轻微并发症。54例采用覆盖性肾造瘘术支架的对照组患者中位住院时间为13.2天，而无管组为7.4天。
结论
单阶段原发性输尿管支架置入术是一种安全的做法，对患者和医疗服务都有普遍益处。
Zotero 插件